BIO Applauds Reps. Sean Duffy and John Carney for Introducing the Corporate Governance Reform and Transparency Act

May 25 2016
Today, the Biotechnology Innovation Organization (BIO) applauds Reps. Sean Duffy (R-WI) and John Carney (D-DE) for introducing the Corporate Governance Reform and Transparency Act. 

BIO Releases Largest Study Ever on Clinical Development Success Rates

May 25 2016
Today, the Biotechnology Innovation Organization (BIO) released the largest study ever of clinical development success rates. The study, conducted in partnership with Amplion and Biomedtracker, recorded and analyzed 9,985 clinical and regulatory phase transitions, across 1,103 companies. Using clinical trial data from the past decade, “Clinical Development Success Rates 2006-2015” compares groups of diseases, drug modalities and other attributes to generate the most comprehensive analysis, to date, of biopharmaceutical R&D success.

BIO Applauds House Passage of the Fostering Innovation Act

May 24 2016
BIO applauds the US House of Representatives for passing H.R. 4139, the Fostering Innovation Act.  The bipartisan legislation was introduced by Reps. Kyrsten Sinema (D-AZ) and Michael Fitzpatrick (R-PA).

Arizona Governor Ducey Signs Bill Ensuring Patient Access to Interchangeable Biologic Medicines

May 23 2016
The Biotechnology Innovation Organization (BIO) and Arizona BioIndustry Association (AZBio) commend Governor Doug Ducey for signing critical legislation to create a pathway for the substitution of interchangeable biologic medicines.

BIO Disappointed in Approps Action to Label GE Salmon

May 19 2016
Senate Ag Committee Efforts Will Better Address Transparency Washington, D.C. (May 19, 2016) – During markup of the FY17 Agriculture Appropriations Bill, the Senate Appropriations Committee approved today by voice vote an amendment to mandate the identification of genetically engineered salmon as “genetically engineered” or “GE” in the marketplace. 

BIO Releases Investment and Deal Making Study Showing Record-Breaking Year for US Venture Capital Funding of Biotech

May 19 2016
Today, the Biotechnology Innovation Organization (BIO) released a new report - Emerging Therapeutic Company Investment and Deal Trends – highlighting ten years (2006-2015) of biotechnology funding and deal making across five areas: venture capital, IPOs, follow-on public offerings, licensing, and acquisitions. 

Top Political Experts to Discuss Presidential Election at 2016 BIO International Convention

May 18 2016
The Honorable Newt Gingrich, Candy Crowley and Stephanie Cutter to participate on keynote panel Wednesday, June 8. A former Speaker of the House, an award winning journalist and a top political strategist will lead a spirited discussion on the 2016 presidential election and its potential impact on the biotechnology industry and the global economy at the 2016 Biotechnology Innovation Organization (BIO) Convention.

BIO Statement on EPA’s Proposed Rule for the 2017 Renewable Fuel Standards

May 18 2016
The proposed rule for the 2017 Renewable Fuel Standard (RFS), issued today by the Environmental Protection Agency (EPA), fails to put the program fully back on track and continues to create uncertainty for advanced and cellulosic biofuel producers and their investors.

NAS Report Upholds Safety of GE Crops and Foods

May 17 2016
There’s no evidence to suggest that foods from genetically engineered (GE) crops are less safe than foods from non-GE crops, according to a new National Academies of Sciences report.

Will Smith to Deliver Keynote at 2016 BIO International Convention

May 13 2016
Actor, producer, musician and philanthropist recently played Dr. Bennet Omalu in the film, “Concussion”